Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study

Lignende værker

• Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
  af: Weiss, Margaret D., et al.
  Udgivet: (2020)
• Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults
  af: Katzman, Martin A., et al.
  Udgivet: (2020)
• Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting
  af: Childress, Ann C., et al.
  Udgivet: (2017)
• NWP06, an Extended-Release Oral Suspension of Methylphenidate, Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study
  af: Wigal, Sharon B., et al.
  Udgivet: (2013)
• Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
  af: Boesen, Kim, et al.
  Udgivet: (2017)